A pH‐Activatable Copper‐Biomineralized Proenzyme for Synergistic Chemodynamic/Chemo‐Immunotherapy against Aggressive Cancers
Advanced Materials · 2023
DOI: 10.1002/adma.202210201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2023. Verfasst von Ting Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Neuropsychiatric Diseases, and College of Pharmaceutical Sciences, Soochow University, Suzhou, 215123, China. Hauptthemen laut MEDLINE: Neoplasms, Nanoparticles. Die Arbeit wurde bisher 93-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Priority Academic Program Development of Jiangsu Higher Education Institutions.
Abstract (Originalsprache)
Artificial enzymes have demonstrated therapeutic benefits against diverse malignant tumors, yet their antitumor potencies are still severely compromised by non‐selective catalysis, low atomic‐utilization efficiency, and undesired off‐target toxicity. Herein, it is reported that peroxidase‐like biomineralized copper (II) carbonate hydroxide nanocrystals inside single albumin nanocages (CuCH‐NCs) act as a pH‐activatable proenzyme to achieve tumor‐selective and synergistic chemodynamic/chemo‐immunotherapy against aggressive triple‐negative breast cancers (TNBCs). These CuCH‐NCs show pH‐sensitive Cu 2+ release, which spontaneously undergoes glutathione (GSH)‐mediated reduction into Cu + species for catalyzing the evolution of H 2 O 2 into hydroxyl radicals (·OH) in a single‐atom‐like manner to cause chemodynamic cell injury, and simultaneously activates non‐toxic disulfiram to cytotoxic complex for yielding selective chemotherapeutic damage via blocking cell proliferation and amplifying cell apoptosis. CuCH‐NCs exhibit considerable tumor‐targeting capacity with deep penetration depth, thus affording preferable efficacy against orthotopic breast tumors through synergistic chemodynamic/chemotherapy, together with good in vivo safety. Moreover, CuCH‐NCs arouse distinct immunogenic cell death effect and upregulate PD‐L1 expression upon disulfiram combination, and thus synergize with anti‐PD‐L1 antibody to activate adaptive and innate immunities, together with relieving immunosuppression, finally yielding potent antitumor efficacy against both primary and metastatic TNBCs. These results provide insights into smart and high‐performance proenzymes for synergistic therapy against aggressive cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of Neuropsychiatric Diseases, and College of Pharmaceutical Sciences, Soochow University, Suzhou, 215123, China.
- Department of Pharmacy, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
- Institute for Interdisciplinary Drug Research and Translational Sciences, Soochow University, Suzhou, 215006, China.
- State Key Laboratory of Radiation Medicine and Protection, and School of Radiation Medicine and Protection, Soochow University, Suzhou, 215123, China.
ORCID-Profile: Huabing Chen
Förderung
- National Natural Science Foundation of China
- National Key R&D Program of China
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Key R&D Plan of Jiangsu Province
- Gusu Innovation and Entrepreneurship Leading Talent Plan
- Suzhou Science and Technology Development Project
- Innovation Capability Support Plan of Shaanxi Province
- Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases
Zitieren
APA
Li, T., Zhang, Y., Zhu, J., Zhang, F., Xu, A., Zhou, T., Li, Y., Liu, M., Ke, H., Yang, T., Tang, Y., Tao, J., Miao, L., Deng, Y., & Chen, H. (2023). A pH‐Activatable Copper‐Biomineralized Proenzyme for Synergistic Chemodynamic/Chemo‐Immunotherapy against Aggressive Cancers. Advanced Materials. https://doi.org/10.1002/adma.202210201
Vancouver
Li T, Zhang Y, Zhu J, Zhang F, Xu A, Zhou T, et al. A pH‐Activatable Copper‐Biomineralized Proenzyme for Synergistic Chemodynamic/Chemo‐Immunotherapy against Aggressive Cancers. Advanced Materials. 2023. doi:10.1002/adma.202210201
BibTeX
@article{Li2023,
author = {Li, Ting and Zhang, Ying and Zhu, Jie and Zhang, Fangrui and Xu, An'an and Zhou, Tian and Li, Yaoqi and Liu, Ming and Ke, Hengte and Yang, Tao and Tang, Yong'an and Tao, Jing and Miao, Liyan and Deng, Yibin and Chen, Huabing},
title = {A pH‐Activatable Copper‐Biomineralized Proenzyme for Synergistic Chemodynamic/Chemo‐Immunotherapy against Aggressive Cancers},
journal = {Advanced Materials},
year = {2023},
doi = {10.1002/adma.202210201}
}
EUVIMED